Advancing Safe Medications for Moms and Babies Act of 2026

This bill would require the Food and Drug Administration to update its rules on protecting people in research so they match Department of Health and Human Services rules on including pregnant women in clinical studies, with final rules due within 180 days. It would create a federal education campaign and public website about clinical trials and registries that include pregnant and breastfeeding women, funded at $5 million per year from 2027 through 2031. It would also direct the National Institutes of Health to fund priority research on drugs prescribed to pregnant and breastfeeding women, set up a process for choosing which projects get priority, and report yearly to Congress on that spending.

Full text and official record on Congress.gov

Sponsors

• Kathy Castor Democrat sponsor
• 2 cosponsors